Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Rebranding
Sort By
Newest First
1 / 1
1 / 1
CDMO Rebranding
Suanfarma Unifies Its Industrial Brands in a Rebranding Initiative Under Suanfarma CDMO
Suanfarma CDMO
PR-M01-24-03
Jan 31, 2024
Brand Relaunch
Techceuticals Announces Relaunch with an Expanded Focus on the Pharmaceutical Industry
Techceuticals
PR-M04-23-02
Apr 25, 2023
Biomanufacturing
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
Scorpius BioManufacturing
PR-M12-22-02
Dec 21, 2022
CDMO
Goodwin Biotechnology Inc. is Now GBI, as Part of their Rebranding Initiative on Their 30-Year Anniversary!
GBI
PR-M12-22-02-179
Dec 09, 2022
Biomanufacturing
New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!
Danielle Alvarez
Pharma's Almanac
PAO-11-022-CL-11
Dec 05, 2022
Rebranding
SCBIO Debuts Refreshed Branding for Life Sciences Organization, Launches New Website
SCBIO
PR-M09-22-08
Sep 29, 2022
Integration
Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse
Actylis
PR-M09-22-06-262
Sep 26, 2022
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01
Sep 07, 2022
M&A
Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene
ProtaGene
PR-M01-22-09
Jan 12, 2022
Rebranding
BIOVECTRA Inc. Looks Inward for New Brand: It’s All About Care
BIOVECTRA
PR-M06-21-013
Jun 04, 2021
Branding
BioVectra's Strategic Brand Update
Oliver Technow
BIOVECTRA
PTV-06-21-CL-001
Jun 02, 2021
Rebranding
Immune Regulation Announces Rebranding to Revolo Biotherapeutics, Reflecting a Revolutionary Approach to Resetting the Immune System to Treat Autoimmune and Allergic Diseases
Revolo Biotherapeutics
PR-M11-20-041
Mar 05, 2021
